Day 1 (June 10) kicks off with the opening session on Microbiome Modulation to Support Women’s Health​, with opening presentations by Dr. Emily Prpa, science manager, Yakult UK & Ireland and Prof. Franco Vicariotto, obstetrician gynecologist, Humanitas Hospital and University Milan, Italy.

This is followed by a presentation about the maternal microbiome and infant health by Dr. Gregory Leyer, scientific consultant, Novonesis, and Anne Karina Riise, global commercial industry manager, Novonesis, before NutraIngredients-USA’s Danielle Masterson moderates a wide-ranging panel discussion on the topic that will feature Prof. Vicariotto; Caroline Carralero, founder and CEO of Nouri; Jordi Riera, chief business officer for Kaneka Probiotics; Hongwei Wang, chief technology officer for BioGrowing; and Dr. Jessica Younes, scientific director at IPA.

After a networking break, Dr. Johanna Maukonen, director of global clinical innovation & translation at IFF, will discuss her company’s work with a novel Akkermansia​ sp. for metabolic health​, and then the program will focus on prebiotics​ for the rest of the day.